Veracyte Inc (NASDAQ: VCYT) has reported earnings for its fourth fiscal quarter (ending December 31) of $0.07 versus a loss $-0.39 for the same period a year ago — a decline of -118%. For the latest four quarters through December 31, E.P.S. were $0.32 compared to $-1.02 a year ago — a decline of -131%.
Recent Price Action
Veracyte Inc (NASDAQ: VCYT) stock rose modestly by 0.5% on 2/24/25. The stock closed at $39.36. Moreover, above average trading volume at 143% of normal accompanied the advance. Relative to the market the stock has been exceptionally strong over the last nine months but has declined -0.6% during the last week.
Current PriceTarget Research Rating
Veracyte has a current Value Trend Rating of C (Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Veracyte has a very low Appreciation Score of 12 but a very high Power Rating of 94, with the Neutral Value Trend Rating the result.
Rating Review
In light of this new information we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment